Biotech Hutchinson China Meditech News Portfolio

Hutchison China Meditech Stops Phase 3 Trial in Pancreatic Cancer Upon Early Success

Biotech News | 21.01.2020

Hutchison China Meditech, also known as Chi-Med, has terminated a phase 3 clinical trial with...

Biotech Hutchinson China Meditech News Portfolio

CK Hutchison Offers 1.3% of Hutchison China Meditech’s Share Capital

Biotech News | 30.09.2019

Hutchison China Meditech Limited, also known as Chi-Med, today announced in London that its...